REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND beta-BLOCKER

摘要

It is intended to establishing the usefulness as a remedy for glaucoma of a combination of an Rho kinase inhibitor, which has a novel function mechanism, with a beta-blocker. By combining the Rho kinase inhibitor with the beta-blocker, the effects of lowering ocular tension of these compounds can be complemented and/or potentiated each other. Concerning the administration form, they can be administered either combinedly or as a mixed preparation.